Department of Cardiology and Angiology, Bergmannsheil University Hospitals, Ruhr University of Bochum, Bochum, Germany.
Department of Molecular and Experimental Cardiology, Institut für Forschung und Lehre (IFL), Ruhr University Bochum, Bochum, Germany.
Eur J Clin Invest. 2023 Jul;53(7):e13977. doi: 10.1111/eci.13977. Epub 2023 Mar 8.
Wearable cardioverter defibrillators (WCD) are used as a 'bridging' technology in patients, who are temporarily at high risk for sudden cardiac death (SCD). Several factors should be taken into consideration, for example patient selection, compliance and optimal drug treatment, when WCD is prescribed. We aimed to present real-world data from seven centres from Germany and Switzerland according to age differences regarding the outcome, prognosis, WCD data and compliance.
Between 04/2012 and 03/2021, 1105 patients were included in this registry. Outcome data according to age differences (old ≥45 years compared to young <45 years) were analysed. At young age, WCDs were more often prescribed due to congenital heart disease and myocarditis. On the other hand, ischaemic cardiomyopathy (ICM) was more present in older patients. Wear days of WCD were similar between both groups (p = .115). In addition, during the WCD use, documented arrhythmic life-threatening events were comparable [sustained ventricular tachycardia: 5.8% vs. 7.7%, ventricular fibrillation (VF) .5% vs. .6%] and consequently the rate of appropriate shocks was similar between both groups. Left ventricular ejection fraction improvement was documented over follow-up with a better improvement in younger patients as compared to older patients (77% vs. 63%, p = .002). In addition, at baseline, the rate of atrial fibrillation was significantly higher in the older age group (23% vs. 8%; p = .001). The rate of permanent cardiac implantable electronic device implantation (CiED) was lower in the younger group (25% vs. 36%, p = .05). The compliance rate defined as wearing WCD at least 20 h per day was significantly lower in young patients compared to old patients (68.9% vs. 80.9%, p < .001). During the follow-up, no significant difference regarding all-cause mortality or arrhythmic death was documented in both groups. A low compliance rate of wearing WCD is predicted by young patients and patients suffering from non-ischaemic cardiomyopathies.
Although the compliance rate in different age groups is high, the average wear hours tended to be lower in young patients compared to older patients. The clinical events were similar in younger patients compared to older patients.
可穿戴式心脏除颤器 (WCD) 被用作暂时存在心脏性猝死 (SCD) 高风险的患者的“桥接”技术。在开具 WCD 时,应考虑患者选择、依从性和最佳药物治疗等因素。我们旨在根据年龄差异,展示来自德国和瑞士七个中心的真实世界数据,包括结局、预后、WCD 数据和依从性。
在 2012 年 4 月至 2021 年 3 月期间,共有 1105 名患者纳入该登记研究。根据年龄差异(老年组≥45 岁与年轻组<45 岁)分析结局数据。在年轻组,WCD 更常因先天性心脏病和心肌炎而被开具。另一方面,老年组中更常见缺血性心肌病 (ICM)。两组的 WCD 佩戴天数相似(p=0.115)。此外,在 WCD 使用期间,记录到的心律失常性危及生命的事件相当[持续性室性心动过速:5.8%比 7.7%,心室颤动 (VF):0.5%比 0.6%],因此两组的适当电击率相似。随访期间记录到左心室射血分数改善,年轻患者改善优于老年患者(77%比 63%,p=0.002)。此外,在基线时,老年组的心房颤动发生率明显更高(23%比 8%;p=0.001)。年轻组的永久性心脏植入式电子设备 (CiED) 植入率较低(25%比 36%,p=0.05)。与老年组相比,年轻组的 WCD 佩戴率(每天至少 20 小时)明显较低(68.9%比 80.9%,p<0.001)。在随访期间,两组的全因死亡率或心律失常性死亡率均无显著差异。年轻患者和非缺血性心肌病患者的 WCD 佩戴率较低。
尽管不同年龄组的依从率较高,但年轻患者的平均佩戴时间较老年患者低。年轻患者与老年患者的临床事件相似。